Dennis Bourgeault
2019
In 2019, Dennis Bourgeault earned a total compensation of $580.8K as Former Chief Financial Officer at Aurinia Pharmaceuticals, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $126,205 |
|---|---|
| Option Awards | $180,784 |
| Salary | $270,145 |
| Other | $3,713 |
| Total | $580,847 |
Bourgeault received $270.1K in salary, accounting for 47% of the total pay in 2019.
Bourgeault also received $126.2K in non-equity incentive plan, $180.8K in option awards and $3.7K in other compensation.
Rankings
In 2019, Dennis Bourgeault's compensation ranked 11,305th out of 13,971 executives tracked by ExecPay. In other words, Bourgeault earned more than 19.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,305 out of 13,971 | 19th |
Division Manufacturing | 4,580 out of 5,701 | 20th |
Major group Chemicals And Allied Products | 1,801 out of 2,200 | 18th |
Industry group Drugs | 1,549 out of 1,886 | 18th |
Industry Pharmaceutical Preparations | 1,147 out of 1,398 | 18th |
Source: SEC filing on May 10, 2021.
Bourgeault's colleagues
We found two more compensation records of executives who worked with Dennis Bourgeault at Aurinia Pharmaceuticals in 2019.